• MJHLS Brand Logo

© 2022 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.

Two experts discuss uterine fibroids and treating the disease as both a provider and payer.

EP. 1: Uterine Fibroids Background

February 21st 2022

Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP, provides a comprehensive background on uterine fibroids, explaining everything from clinical burden to symptoms.

EP. 2: Quality of Life and the Typical Patient Journey With UF

February 21st 2022

Dr Al-Hendy discusses the impact UF has on a patient’s life and their typical patient journey through the healthcare system.

EP. 3: The Economic Burden of UF

April 8th 2022

Maria Lopes, MD, discusses the economic burden of UF from a payer’s perspective, explaining direct and indirect costs associated with the condition.

EP. 4: UF Risk Factors

April 8th 2022

Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP, elaborates on risk factors for the development of UF.

EP. 5: A Changing Treatment Paradigm in UF

April 18th 2022

Dr Ayman Al-Hendy details the shift from surgical options to medical therapy for patients with UF.

EP. 6: UF Treatment Goals

April 18th 2022

Dr Al-Hendy briefly explains how he determines treatment goals during initial workups for patients with UF.

EP. 7: GnRH Receptor Antagonists in UF

April 22nd 2022

Dr Al-Hendy highlights the oral GnRH receptor antagonists as first-line therapy for UF.

EP. 8: Managing UF Treatment

April 22nd 2022

Dr Lopes discusses the typical payer challenges with managing UF treatment, including pain management.

EP. 9: Healthcare Disparities in Women’s Reproductive Health

April 29th 2022

Dr Maria Lopes provides an overview of common disparities seen when treating and maintaining women’s reproductive health and how these can be minimized.

EP. 10: Unmet Needs for UF Treatment

April 29th 2022

Drs Lopes and Al-Hendy describe the unmet needs they see when treating patients with UF.